updated guidance on evaluating and testing persons

Submit Demands Online

26 06 2020Evaluating and Managing COVID-19: Guidance for the UTMB Community Jun 26 2020 15:39 PM by COVID-19 Clinical Task Force In view of the rapid surge of COVID-19 infection in our region the entire UTMB community—including faculty staff and students—has to be vigilant at work and in the community to prevent exposure and if ill to quickly get tested and not be at work or in the lab or Updated Guidance on Evaluating and Testing Persons for Coronavirus Disease 2019 the CDC recently updated the FAQ website for laboratories and we encourage you to read through the site to answer preliminary questions though we stand ready to answer other questions that you may have Guidance to Prepare Homeless Shelters

Testing Guidance

Prioritizing Patients for Testing Updated COVID-19 Testing Guidance for Alameda County (ACPHD 5/12/20) Evaluating and Testing Persons for COVID-19 (CDC) Setting Up Testing Sites COVID-19 Testing Site Requirements (ACPHD 3/30/20) Testing Referrals Providers who are not offering testing can refer their patients who need testing to our Testing for COVID-19 page where they can find testing

Earlier this month the Criminal Division of the United States Department of Justice (DOJ) updated its Evaluation of Corporate Compliance Programs guidance In considering enforcement actions against companies prosecutors use the guidance to assist in evaluating (1) the form of any resolution or prosecution (2) the amount of a monetary penalty if any and (3) whether to impose compliance

On June 1 2020 the U S Department of Justice Criminal Division released an update to its guidance on the Evaluation of Corporate Compliance Programs ("2020 Guidance") [1] which is intended to assist prosecutors in making informed decisions about whether a company's compliance program was effective at the time of the offense and whether it is effective at the time prosecutors are make

CDC guidance for COVID-19 may be adapted by state and local health departments to respond to rapidly changing local circumstances Revisions were made on May 3 2020 to reflect the following: Updated recommendations for testing specimen collection and reporting patients and reporting positive test results Specification of testing priorities Summary of other changes No vaccine

Recognizing persons who are at risk for COVID-19 is a critical component of identifying cases and preventing further transmission With expanding spread of COVID-19 additional areas of geographic risk are being identified and the criteria for considering testing are being updated to reflect this spread

Health Alert Network (HAN)

Updated Guidance on Evaluating and Testing Persons for Coronavirus Disease 2019 (COVID-19) - Health Alert Network (HAN) No 429 The Centers for Disease Control and Prevention (CDC) continues to closely monitor and respond to the COVID-19 outbreak caused by the novel coronavirus SARS-CoV-2 This CDC Health Alert Network (HAN) Update provides updated guidance on evaluating and testing persons

Updated Guidance for Optimizing the Supply of PPE (Updated March 17 2020) April 16 2020 UPDATED Interim Guidance for Clinicians Evaluating Reporting and Requesting Diagnostic Testing for Possible COVID-19 Cases GUIDANCE SUBJECT TO CHANGE Please read this guidance in its entirety Summary

The CDC also updated its guidance on contract tracing and evaluating and testing persons for COVID-19 (Updated 5/4/20) Centers for Medicare Medicaid Services The Centers for Medicare and Medicaid Services (CMS) latest news alerts (Updated 5/7/20) And for the latest COVID-19 related CMS guidance visit the CMS Current Emergencies webpage

Evaluating and Reporting Persons Under Investigation (PUI) Distributed by: The City of Middletown Health Department Summary of Recent Changes Revisions were made on March 4 2020 to reflect the following: x Criteria for evaluation of Persons Un der Investigation (PUI) were expanded to a wider group of symptomatic patients Revisions were made on February 28 2020 to reflect the following: x

This is an official CDC HEALTH UPDATE Distributed via the CDC Health Alert Network March 08 2020 8:20 PM ET CDCHAN-00429 Updated Guidance on Evaluating and Testing Persons for Coronavirus Disease 2019 (COVID-19) Summary The Centers for Disease Control and Prevention (CDC) continues to closely monitor and respond to the COVID-19 outbreak caused by the novel coronavirus SARS-CoV

In addition to reviewing the Updated Guidance on Evaluating and Testing Persons for Coronavirus Disease 2019 the CDC recently updated the FAQ website for laboratories and we encourage you to read through the site to answer preliminary questions though we stand ready to answer other questions that you may have

Interim Guidance for Collection and Submission of Postmortem Specimens from Deceased Persons Under Investigation (PUI) for COVID-19 February 2020 CDC has updated its guidance on what specimens to collect when testing for COVID-19 The latest guidance is available online at Evaluating and Testing Persons for Coronavirus Disease 2019 (COVID-19)

Direct-observed self-administered specimen collection for COVID-19 testing: 2020 the CDC updated guidance regarding specimen collection for COVID-19 testing that included an option for self-administered specimen collection with direct observation by a health care professional On May 5 2020 1 the CDC also updated guidance that testing can be performed on asymptomatic individuals who are

HCSWPA

Actions Information and Guidance about Global Travel on Cruise Ships Including River Cruises - Mar 15 2020 Actions Updated Guidance on Evaluating and Testing Persons for Coronavirus Disease 2019 (COVID- - Mar 8 2020 Actions Update and Interim Guidance on Outbreak of Coronavirus Disease 2019 (COVID-19) - Health - Feb 28 2020

HEALTH ALERTS SRC # SUBJECT DATE WV: 168: Expanding Testing for COVID-19: Clinician-Suspected Re-infection : June 8 2020: WV: 167: Vector-borne Disease Season: June 4 2020: WV: 166: COVID-19: June 3 2020: CDC: 429: Updated Guidance on Evaluating and Testing Persons for Coronavirus Disease 2019 (COVID-19) March 8 2020: WV: 165: Coronavirus Disease 2019 (COVID

HEALTH ALERTS SRC # SUBJECT DATE WV: 168: Expanding Testing for COVID-19: Clinician-Suspected Re-infection : June 8 2020: WV: 167: Vector-borne Disease Season: June 4 2020: WV: 166: COVID-19: June 3 2020: CDC: 429: Updated Guidance on Evaluating and Testing Persons for Coronavirus Disease 2019 (COVID-19) March 8 2020: WV: 165: Coronavirus Disease 2019 (COVID

Recognizing persons who are at risk for COVID-19 is a critical component of identifying cases and preventing further transmission With expanding spread of COVID-19 additional areas of geographic risk are being identified and the criteria for considering testing are being updated to reflect this spread In addition with increasing access to

Health Advisory: Updated Symptom List and Testing Guidance For Use When Evaluating Patients for COVID-19 April 29 2020 Action requested: • Be familiar with updated CDC list of symptoms for which COVID-19 should be considered • Be familiar with new Washington DOH guidelines for COVID-19 testing to include all patients with

Guidance for Evaluating Soil Vapor Intrusion in Washington State: Ecology developed this guidance to assist potentially liable persons (PLPs) 1 site managers and consultants evaluating vapor intrusion as part of applying the Model Toxics Control Act (MTCA) cleanup regulations The guidance contains: A process for evaluating the vapor intrusion pathway during a remedial investigation and

Updated Guidance on Evaluating and Testing Persons for Coronavirus Disease 2019 (COVID-19) Save as PDF Distributed via the CDC Health Alert Network March 08 2020 8:20 PM ET CDCHAN-00429 Summary The Centers for Disease Control and Prevention (CDC) continues to closely monitor and respond to the COVID-19 outbreak caused by the novel coronavirus SARS-CoV-2 This CDC Health

CDC Guidance: Updated Guidance Evaluating and Testing Persons for COVID-19 (03/08/20) CDC Lab Information: CDC Information for Laboratories FDA Resources: Testing-Related EUAs Resources Guidance on Antibody Testing Abbott Point-of-Care Test: On May 14 the FDA announced that based on early data the Abbott ID NOW point-of-care test to diagnose COVID-19 may return false